I wasn’t sure about having a ‘test-tube baby’ – Chicago Tribune

When I first visited a fertility doctor because of pregnancy problems, I had no idea that the in vitro fertilization, or IVF, he was suggesting to help me was actually the "test-tube baby" technique that I'd heard about, an approach that had sounded scary, like something out of science fiction.

After I educated myself and started treatment, the concerns continued: Would the hormone-stimulating drugs have adverse effects on me? What would the drugs do to the fetus? And more important, would conceiving a child outside the womb (not actually in a test tube but in an embryology lab) have any long-term effects? Most important, would my child - if I would be lucky enough to give birth to one - be as physically and mentally healthy as naturally conceived children?

Articles and blogs fed into my worries - not to mention the online "mommy boards" at pregnancy and fertility websites where women trade rumors, innuendoes and fears, often based on nothing more than a friend's experience.

Since the first test-tube baby, Louise Brown, was born in England in 1978, about 6.5 million children have been born worldwide with the help of assisted reproductive technologies (ART) such as IVF. So there is now enough information to address my concerns. Overall, those findings leave me pretty confident that the risks are pretty small and well worth taking if, like me, you want to have a baby but can't.

Although taking fertility medications drove me crazy - some hormones gave me nightmares, others kept me up at night, and the main ones made my mind race loopily - looking at studies allowed me to conclude that IVF probably has no long-term bad effects.

For instance, a 2013 study of 21,646 women in Australia concluded that "there is no evidence of an increased risk of ovarian cancer following IVF in women who give birth." Another study of 9,825 American women found no link between gonadotropins - the drugs I was taking to increase my egg production - and ovarian cancer for women who gave birth. There was one worrisome point: Both studies found an increased cancer risk for women with "resistant infertility" - i.e., those who did not give birth - although the researchers did not know why.

A recent study in the journal JAMA of about 25,000 women who had fertility treatments between 1980 and 1995 found that those who had gone through IVF had no greater risk of getting breast cancer in the subsequent 21 years than those who used other techniques.

Whew. I went through nine rounds of IVF before I got pregnant, which means I took a lot of ovary-stimulating drugs, so these studies are reassuring.

"Numerous studies and opinions from [the American Society for Reproductive Medicine] confirm low risk for ovarian and breast cancer from the use of fertility drugs, regardless of the number of IVF cycles performed," said Jeffrey Braverman, founder and medical director at Braverman IVF & Reproductive Immunology in New York.

So how about risks to the baby? Would he or she be affected by her medically assisted conception?

Two studies have raised concerns.

A 2016 study in JAMA Pediatrics found increased risk for birth defects in babies conceived through ART. The study, which involved more than 4 million infants, found that "singleton infants conceived using ART were 40 percent more likely to have a nonchromosomal birth defect (such as cleft lip and/or palate or a congenital heart defect) compared with all other singleton births."

The researchers acknowledged that the study "did not account for some factors related to infertility that might explain the observed increases in risk for birth defects." In other words, IVF may not have caused the defects. They recommended further research.

A comprehensive review of a group of other studies suggested that the risk for developmental disabilities was greater with ART - which, in addition to IVF, includes egg freezing and surrogacy - than with natural childbirth. The review examined studies of IVF and autism, cerebral palsy, intellectual disability, attention-deficit/hyperactivity disorder and sensory impairment, among others, and found conflicting information, no correlation or that the disabilities could have been caused by other factors such as preterm birth.

And a study published in March found an increased risk of neoplasms - tumors that can be benign or malignant - in children born through ART.

But I focused on a study that followed children conceived with ART into their teenage years. It offers a much more reassuring view. The study, published in January, compared 253 16- and 17-year-olds who were conceived with fertility treatments to a cohort of teenagers conceived naturally and found that "no differences were detected in general and mental health of ART adolescents or cognitive ability, compared with the reference group." The researchers, who said this was the first long-term study of such children, concluded that their "preliminary results provide reassurance that in the long run, health and functioning of ART-conceived adolescents is not compromised."

One of the researchers on the study, Mark Weiser, a psychiatry professor at Tel Aviv University's Sackler School of Medicine, said in an interview that the findings should be a relief to parents who used IVF and other assisted reproductive technology. "We show there is nothing wrong with these kids" when compared with children born naturally. "This is a very positive message to parents who are not able to get pregnant on their own. If you look down the line, the kids are perfectly normal."

As for me: After an uneventful pregnancy, my daughter was born full term nearly two years ago at a healthy six pounds, six ounces, with all her fingers and toes and brown hair that would soon turn to curls. She is a delightful, chatty, feisty toddler. Every parent worries about their child, and I know that I will be no different. But for now it seems clear to me that the risks of having used IVF were minimal - and the reward huge.

Go here to read the rest:
I wasn't sure about having a 'test-tube baby' - Chicago Tribune

Darwin’s Idea – The Times (subscription)

June 12 2017, 12:01am,The Times

Cities are observably shaping the evolution of physical organisms

The diversity of species, living and extinct, was once thought by all sophisticated people to be explicable by the actions of a divine creator. In perhaps the most important intellectual advance in human history, the right explanation was arrived at less than 200 years ago by Charles Darwin.

Though Darwin did not originate the concept of evolution, he explained its basic mechanism of natural selection and random mutation. His conclusions are substantiated by mountains of evidence from the fossil record, embryology, molecular biology, the geographical distribution of plants and animals, and much else.

Now there is evidence of evolution at greater speed than anything previously observed. Modern humans live increasingly in cities and, as science would predict, organisms adapt to their environment. Pigeons and other

Read the rest here:
Darwin's Idea - The Times (subscription)

Chicago Medical School Launches Stem Cell Biology Center – Peoria Public Radio

A medical school in Chicago is launching a new center to study tissue regeneration and stem cell biology.

The College of Medicine at the University of Illinois at Chicago says there will be a symposium to commemorate the opening of the center, which will be housed at the medical school.

Officials say researchers will study molecular signals that drive stem cells to mature into different types of cells, among other topics. They'll also investigate issues such as the best ways to transplant engineered cells.

Several different professors will be involved, including the head of the university's pharmacology department.

University officials say there's a search underway to find a director and additional faculty.

See the article here:
Chicago Medical School Launches Stem Cell Biology Center - Peoria Public Radio

Mitochondria Behind Blood Cell Formation – Northwestern University NewsCenter

Mitochondria are tiny, free-floating organelles inside cells. New Northwestern Medicine research has discovered that they play an important role in hematopoiesis, the bodys process for creating new blood cells.

New Northwestern Medicine research published in Nature Cell Biology has shown that mitochondria, traditionally known for their role creating energy in cells, also play animportant role in hematopoiesis, the bodys process for creating new blood cells.

Historically, mitochondria are viewed as ATP energy producing organelles, explained principal investigator Navdeep Chandel, PhD,the David W. Cugell Professor ofMedicinein the Division ofPulmonary and Critical Care Medicine. Previously, my laboratory provided evidence that mitochondria can dictate cell function or fate independent of ATP production.We established the idea that mitochondria are signaling organelles.

In the currentstudy, Chandels team, including post-doctoral fellow Elena Ans, PhD, and graduate students Sam Weinberg and Lauren Diebold, demonstrated that mitochondria control hematopoietic stem cell fate by preventing the generation of a metabolite called 2-hydroxyglutarate (2HG). The scientists showed that mice with stem cells deficient in mitochondrial function cannot generate blood cells due to elevated levels of 2HG, which causes histone and DNA hyper-methylation.

This is a great example of two laboratories complementing their expertise to work on a project, said Chandel, also a professor ofCell and Molecular Biologyand a member of theRobert H. Lurie Comprehensive Cancer Center of Northwestern University.

Sam Weinberg, a graduate student in the Medical Scientist Training Program, and Lauren Diebold, a graduate student in the Driskill Graduate Program in Life Sciences, were co-authors on the paper.

Paul Schumacker, PhD, professor of Pediatrics, Cell and Molecular Biology and Medicine, was also a co-author on the paper.

Chandel co-authored an accompanying paper in Nature Cell Biology, led by Jian Xu, PhD, at the University of Texas Southwestern Medical Center, which demonstrated that initiation of erythropoiesis, the production of red blood cells specifically, requires functional mitochondria.

These two studies collectively support the idea that metabolism dictates stem cell fate, which is a rapidly evolving subject matter, said Chandel, who recently wrote a review in Nature Cell Biology highlighting this idea. An important implication of this work is that diseases linked to mitochondrial dysfunction like neurodegeneration or normal aging process might be due to elevation in metabolites like 2HG.

This research was supported by National Institutes of Health grants R35CA197532, T32GM008061, T32 T32HL076139, K01DK093543 and R01DK111430, and Cancer Prevention and Research Institute of Texas New Investigator award RR140025.

Read more here:
Mitochondria Behind Blood Cell Formation - Northwestern University NewsCenter

A single molecule is missing and the cell world is empty – Phys.Org

June 12, 2017 Dynamic remodeling in ESCRT-III polymers. Vps4 mediates turnover of ESCRT-III subunits within growing and constricting polymers - analogous to Lego figures exchanging the building blocks within a large spiral assembly. Credit: Beata Edyta Mierzwa, BeataScienceArt.com

Cells multiply by duplicating themselves: they grow, replicate their components, and finally split into two. Many diseases are related to defective cell division; cancer is one of them. Understanding mechanisms conducting this division is therefore essential in the search for cancer treatments. Researchers at the University of Geneva (UNIGE), Switzerland, in collaboration with the IMBA- Institute of Molecular Biotechnology at the Vienna BioCenter (VBC) and the Weill Cornell Medical College in New York, have turned their attention in particular to the role of ESCRT proteins, which are responsible for severing cell membranes. These proteins assemble in spirals that gradually bring about cleavage of the membrane, spirals that are constantly renewing themselves with the help of the Vps4 molecule. Without this molecule the renewal stops, eventually preventing the membrane from being severed. This research, reported in the journal Nature Cell Biology, sheds new light on the fight against cancer and HIV, both of which depend on cell division.

In a previous research, the team led by Professor Aurlien Roux of the Department of Biochemistry at the Faculty of Sciences of the UNIGE, discovered that ESCRT proteins assemble in the form of spirals, a structure that is unique amongst the many forms created by the organism's filamentous proteins. Why this unique form? During cell division, the cell contracts at its centre to separate the two daughter cells. At the end of this stage, called cytokinesis, a very thin link remains between the cells, a tube of plasma membrane - the cell's skin - called the "cytoplasmic bridge". The spirals formed by ESCRT proteins coil around the inner surface of this tube and constrict it in order to sever it, a stage called abscission. Professor Roux's team showed that these spirals behaved like the springs of a watch, suggesting a scenario wherein the more the ESCRT proteins assembled, the more tightly they were compressed.

Research conducted simultaneously in vitro and in vivo

After discovering why these molecules assembled in spirals, the UNIGE researchers examined the dynamics of the assembly. Until now scientists have thought that they assembled like Lego blocks, the proteins being added progressively to the structure without ever leaving it. In this new study, biochemists were able to invalidate this hypothesis. To do so they joined forces with the Gerlich group at IMBA, Vienna Biocenter, to conduct the experiment simultaneously in vivo (the Viennese scientists' part) and in vitro (the Genevan scientists' part).

"On our side, we observed the dynamics of the ESCRT proteins by isolating them on a flat artificial membrane that we created using lipids, onto which we placed the ESCRT protein complexes," explains Nicolas Chiaruttini, a research scientist at UNIGE. "And contrary to what we thought, the proteins do not form a rigidly fixed spiral that is compressed; instead there is a constant renewal of proteins, creating supple, mobile spirals in constant motion." Using a new imaging technique, the team led by Simon Scheuring in New York, working in collaboration with the UNIGE team, was able to directly visualize the dynamics and flexibility of these spirals. Conducting further research, the biochemists noted that this renewal cannot occur without the Vps4 molecule, which is an integral part of ESCRT protein complexes. "Vps4 is known for disassembling molecules in polymeric structures," says Aurlien Roux. "So it is the indispensable ingredient for the severing of membranes insofar as it enables the renewal of spirals."

It is worthwhile noting that the Viennese researchers reached exactly the same conclusions. "During our observations in the cell in motion, Vps4 was revealed to be necessary for the renewal of spirals," explains Beata Mierzwa, a researcher at IMBA-VBC. More importantly, the team observed that the absence or inactivation of Vps4 inhibited cell division in 50% of cases and delayed it significantly in the other 50%. Vps4 and the constant renewal of ESCRTs appear, therefore, to be essential for abscission. "It is rare to be able to conduct experiments in vivo and in vitro simultaneously, and the fact that the results coincide firmly establishes our study."

Another way to approach cancer and HIV

Cancer is characterized by excessive multiplication of diseased cells. By elucidating the role of the Vps4 molecule in cell division, researchers have decipher mechanisms that could be targeted as new treatments that would, for instance, block ESCRT protein renewal directly, thereby preventing the proliferation of the disease. Similarly, when a cell is infected by the Human Immunodeficiency Virus, virus particles bud from the membrane, then eventually break off from it to infect other cells. The virus must also sever the cell membrane in order to be released and spread the diseasea stage that is also carried out by ESCRT proteins. Here again, targeting the Vps4 molecule could prevent the virus from leaving the infected cell.

The primary role of fundamental research is not to find new drugs for cancer or AIDS traitements, but rather, by understanding how ESCRT and Vps4 participate in cell division and virus replication, "to provide knowledge essential to treat those diseases, and clues about potential interactions between treatments", concludes Aurlien Roux.

Explore further: Researchers discover a new mechanism that deforms cell membranes

More information: "Dynamic subunit turnover in ESCRT-III assemblies is regulated by Vps4 to mediate membrane remodelling during cytokinesis," Nature Cell Biology (2017). DOI: 10.1038/ncb3559

Cell membranes are very elastic. They can become distorted when they are asked to do so, when the cell divides, or when a virus detaches itself from the cell. In both cases, the membrane is deformed by a protein complex called ...

Biologists from Indiana University and Montana State University have discovered a striking connection between viruses such as HIV and Ebola and viruses that infect organisms called archaea that grow in volcanic hot springs. ...

(Phys.org)To remove waste from cells, a class of membrane-sculpting proteins create vesiclesmolecular trash bagsthat carry old and damaged proteins from the surface of cellular compartments into internal recycling ...

For two independent daughter cells to emerge from a cell division, the membrane of the dividing cell must be severed. In the latest issue of Science, a team led by Daniel Gerlich, Professor at the Institute of Biochemistry ...

A research team led by St. Jude Children's Research Hospital immunologists has discovered how a set of proteins delays the "executioner" machinery that kills damaged or infected cells in a process called necroptosis. The ...

Cornell researchers have provided new insight into the molecular mechanism underlying an essential cellular system. They have discovered how receptors on cell surfaces turn off signals from the cell's environment, a function ...

Scientists are closer to unraveling the long-standing mystery of how tiny glass eel larvae, which begin their lives as hatchlings in the Sargasso Sea, know when and where to "hop off" the Gulf Stream toward European coastlines ...

A combined team of researchers from the University of Arkansas and Cornell University has found that a type of fungus kills female goldenrod soldier beetles in a unique wayby causing them to attract males, which assists ...

A promiscuous salamander has found a simple genetic formula for success: Mate with multiple males and use equal parts of each partner's genetic material in her offspring.

Imagine if a dense thicket didn't obstruct your path but instead picked you up and shuttled you through the forest. That's what tightly packed DNA might be doing with important life molecules to get them where they're needed ...

Islands and populated coastal areas are the world's "hotspots" for invasive species, which can upend entire ecosystems and drive local animals and plants to extinction, a study reported Monday.

Humans are responsible for the movement of an increasing number of species into new territories which they previously never inhabited. The number of established alien species varies according to world region. What was previously ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Read the original:
A single molecule is missing and the cell world is empty - Phys.Org

Celgene bags option on NK cell-based blood cancer assets – FierceBiotech

Celgene has landed an option on four natural killer (NK) cell-based blood cancer therapeutics in a deal with Dragonfly Therapeutics. The agreement sees Celgene hand over $33 million and commit to more in milestones to access next-generation immuno-oncology candidates aimed at some of its core therapeutic areas.

Cambridge, Massachusetts-based Dragonfly has given Celgene the exclusive option to license up to four assets designed to treat acute myeloid leukemia, multiple myeloma and other hematological cancers. The candidates will emerge from a platform that Dragonfly sees establishing NK cell alongside T cells as a critical component of the push to weaponize the immune system to defeat cancers. Celyad and Innate Pharma have landed deals on the strength of their own attempts to use NK cells.

Dragonflys platform generates bridges designed to bind to proteins found on the surface of tumor cells and NK cells. The aim is to stimulate NK cells. Once activated and aware of the presence of the cancer cells, NK cells attack tumors directly while also enlisting the support of T and B cells. T cells, the cornerstone of current immuno-oncology approaches, then join the direct attack on the tumor, while B cells produce antibodies to help the fight against the cancer.

The potential of the approach has attracted the attention of Celgene.

NK-cell biology and immunotherapy are increasingly critical areas of hematologic research and we are looking forward to working with Dragonflys team of world-leading experts, Rupert Vessey, D.Phil., Celgenes president of research and early development, said in a statement. This collaboration will leverage the strengths of each company as we work together to bring innovative therapies to patients.

The discovery-stage biotech is a long way from showing its biological linker molecules can trigger the desired immune responses. But Celgene, in keeping with its willingness to make early bets on promising biotechs, has seen enough potential in Dragonfly to follow up last months equity investment with the R&D pact.

At this early stage, the perception of potential rests partly on the identities of the people involved with Dragonfly. Tyler Jacks, Ph.D., who heads up the Koch Institute for Integrative Cancer Research at MIT and co-chairs the White Houses Cancer Moonshot, is one cofounder. UC Berkeley NK cell specialist David Raulet, Ph.D., is another. Jacks and Raulet are joined by serial environmental entrepreneur Bill Haney, who brings his experience of building startups, albeit outside of life sciences, to the role of CEO of Dragonfly.

The trio have put together a scientific advisory board that features Nobel Prize winner Harold Varmus, M.D.a former director of the National Cancer Instituteand other researchers from MIT, Stanford University and MD Anderson Cancer Center.

Dragonfly has used these credentials to raise an undisclosed amount of cash from an unusual mix of investors. Celgene sits alongside members of the Disney family and the Duke of Bedford on the list of people and organizations to put money into Dragonfly to date.

The involvement of Celgene in a discovery-stage company that has largely eschewed traditional sources of investment in favor of cash from family offices is in line with its history of spotting and backing biotechs earlier than its peers. Celgene, under the management of George Golumbeski, Ph.D., andTom Daniel, M.D., got in on the ground floor at companies including Agios Pharmaceuticals, Bluebird Bio and Foundation Medicine. And it has had the confidence to put up eye-watering sums of money, such as the $1 billion it gave Juno Therapeutics in return for equity and an option on its immuno-oncology programs.

Continue reading here:
Celgene bags option on NK cell-based blood cancer assets - FierceBiotech

Anatomy of a Suicide review a startling study of mothers and daughters – The Guardian

What determines our character? Nature or nurture? Genetic inheritance or social environment? It is an age-old debate, and Alice Birch now adds to it with this startling theatrical triptych about three generations of mothers and daughters. Whatever my doubts about Birchs conclusion, the play is odd, arresting and, in Katie Mitchells immaculate production, highly original in its form.

Birchs progress as a writer has been fascinating to watch. She delivered a short, sharp shock in 2014 with Revolt, She Said, Revolt Again which was a subversive, playful piece calling for revolution in everything from sexual relationships to the workplace. In 2015, the Orange Tree brought us an earlier Birch play, Little Light, about sibling rivalries, that suffered from too much withheld information. Since then Birch has written a polemical piece about porn, We Want You to Watch; the admired Ophelias Zimmer, which I missed; and the recent film Lady Macbeth, which transposed a Russian novel to Victorian England and got a five-star review from Peter Bradshaw.

On the evidence so far, I would say Birch has a gift for radical experiment in the style of Caryl Churchill and Sarah Kane. In her new play we are confronted by three women, Carol, Anna and Bonnie, who we learn are mother, daughter and granddaughter. They exist in three different time zones but the story of their lives is told simultaneously. As Birch herself says, the text has been scored and can be read, or viewed, horizontally. In practical terms that means that, as dialogue and action often overlap, we decide where to focus our attention.

It is simpler than it sounds. We first meet Carol when she is emerging from hospital having tried to kill herself by slitting her wrists; subsequently giving birth does little to quell her visible unease. While following Carols story, we also see her grownup daughter Anna suffering from drug addiction, joining a commune and marrying a documentary film-maker by whom she has a daughter. That daughter, Bonnie, has grown up to be a skilled physician who is gay, guarded in her relationships and determined to avoid the possibility of procreation.

If I say that panels above the stage reveal early scenes to be taking place in 1973, 1998 and 2033 and that by the end the story has moved on by roughly a decade, you will get the general idea.

So what is Birch suggesting? Evidently that inherited suicide is a possibility and that the trauma of Carols life is transmitted to the next generation and beyond. I am not qualified to say whether that is psychologically true, but behind the play lies a genetic determinism that I resist. We all know what Larkin said about what parents do to their children (They fuck you up) but Birchs play leaves little scope either for self-invention or the impact of social and economic forces. Even Bonnies choice of profession seems shaped by her grandmothers actions, and you are led to wonder whether Carols momentary surrender to a womans kiss has some connection with Bonnies sexual preference.

Even if I question many of Birchs assumptions, she has found the ideal form in which to explore her subject. I can, in fact, think of few exact parallels to this play. Charlotte Keatley in My Mother Said I Never Should interwove four generations of mothers and daughters and Edward Albee in Three Tall Women cross-cut between the different stages of his adoptive mothers life. But Birch not only presents three lives concurrently but deftly establishes overt and subliminal links between them: Carols anguish over childbirth is echoed in Annas experience and even a word such as radiant takes on varied associations when applied to all three characters.

Mitchells production is characteristically precise and detailed, and Alex Ealess design of a strip-lit institutional room with five doors proves highly adaptable.

Casting also ensures that the three women, although linked by blood, are idiosyncratically different. Hattie Morahan plausibly lends Carol the air of a once-golden girl infinitely baffled by her inability to find happiness in marriage or parenthood. Kate OFlynn exactly captures Annas congenital instability and resentment at being treated by her future husband as a case history. Adelle Leonce meanwhile is all wariness and isolation as Bonnie, and there is good support from Jodie McNee as her ardent suitor and Paul Hilton as Carols perplexed husband.

Its a play that raises many more questions than it answers but for two uninterrupted hours it kept me hooked. It also confirms that Birch is a questingly experimental writer who, even if she insufficiently acknowledges our capacity to escape our parental legacy, has a remarkable gift for reinventing dramatic form.

At the Royal Court theatre, London, until 8 July. Box office: 020-7565 5000.

In the UK, the Samaritans can be contacted on 116 123. In the US, the National Suicide Prevention Hotline is 1-800-273-8255. In Australia, the crisis support service Lifeline is on 13 11 14. Hotlines in other countries can be found here.

Read more here:
Anatomy of a Suicide review a startling study of mothers and daughters - The Guardian

Beauty brands embrace the appeal of neuroscience – Inquirer.net

Mood-boosting beauty pioneer Benefit Cosmetics continues to lead the feel-good retail movement. Image: Benefit Cosmetics US/Instagram via AFP Relaxnews

According to recent findings by top think tank Peclers Paris, more and more millennial fashion and beauty brands are tapping into the strong consumer demand for mood-oriented products and interaction.

Leading brands such as Benefit Cosmetics are eschewing traditional marketing spiel in a move to create a closer emotional connection with their consumers.

A no-brainer, if you follow leading expert on emotions Antonio Damasios reasoning that 80 percent of our choices and decisions are driven by our emotions.

Biometrics and neuroscience are being brought into the mix to enhance our overall retail experience. Face reading and mood-tracking technologies are examples of these new ways of garnering interest and enticing shoppers to come back for more.

Japanese clothing brand Uniqlo was one of the pioneers of the trend back in 2005 when it launched UMood, algorithm-based brainwave sensing technology that was designed to help customers find the perfect t-shirt from 600 styles, to suit their emotional state.

Beauty brands often use seductive product names in the hopes of tapping into consumers deep-seated desires.

Cliniques Happy fragrance and Benefits Dr Feel Good complexion balm; the list goes on. While the concept of mood-boosting fragrances or makeup is not new, digital marketers are going the extra mile by lavishing more attention on consumers moods and general well being.

Benefit is a case in point. The San Francisco-born beauty giant has built its reputation on playfully engaging with consumers, announcing, for instance that laughter is the best cosmetic despite boasting an army of best-selling beauty products.

Earlier this year, Benefit raised brows with the launch of its brow translator tool. The mood-gauging microsite unabashedly surfs the browcentric beauty trend, thanks to the likes of Cara Delevingne, enabling internet users the opportunity to upload pictures of their eyebrows and find out what they say about them.

With the help of neuroscientist Dr. Javid Sadr from Canadas University of Lethbridge, Benefit came up with a face-reader, which analyses the upper part of the face to determine emotional expression and adds an enhancing effect. Arched, narrow, knitted, neutral; our brows speak volumes about how sassy, happy or sad we are feeling.

Benefit captured their market research in this video, showing passers-by how to define their brows with their online brow translator.

Meanwhile, indie brand Chaos Makeups buzzed-about, soon-to-be launched Mood Cream not only plays upon a changing emotional connection between product and user in its name but also has nostalgic appeal by evoking thermochromatic mood rings from times past. The multi-purpose color-shifting cream changes color with exposure to water or heat. JB

RELATED STORY:

Heres the Deal Behind Alicia Keys #NoMakeup Music Video Look

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

See original here:
Beauty brands embrace the appeal of neuroscience - Inquirer.net

Human Behavior Creates Predictable Chart Patterns – Investing.com

It was an interesting week in the stock market, with plenty of fear and greed to go around. Same as it ever was, right? As we analyze emotions and behavior they seem to parallel the price action in markets. Excessive greed pushes prices ever higher, We saw new highs this week in names like Amazon (NASDAQ:) and Google (NASDAQ:), while all of the most prominent indices at some point hit record highs during the week.

As prices continue to rise volatility shrinks and the perception about market action becomes more 'predictable', and that could be troublesome. Anyone who tries to predict market action and behavior has certainly seen his share of losses - especially if it was down. Oh, we have seen downside over the years, but the longer term trend has been higher as the moves lower have been steep, sharp and quick.

As we analyze price patterns we see behavior show up in recognizable patterns. Let's study the chart of recent high flyer NVIDIA (NASDAQ:). This stock was the top mover in the last year, up a stunning 300%. Many believed those days were behind it and most likely the stock was going to head sideways for an extended period. The stock hit new all time highs last week and pushed much higher than anyone would have expected. But as we can see from the daily chart, at least in 2017 there have been a few interruptions, and we have just seen another if the previous pattern plays out again.

Earlier this year, NVIDIA encountered two nasty selling days on heavy volume, and as we would expect there was followthrough to the downside. These followed sharp moves to the upside. Those trying to catch a falling knife were bloodied and beaten up by not waiting for the selling to subside. Prices did eventually rise however, and this last move from the 102 area in May up to 167 was just stunning.

But look at the poor action June 9 and we can see the setup for more downside first before the stock may head back up. Clearly the fear was evident by the extreme selling and massive turnover. Higher price levels were rejected and when that happened the floodgates opened and sellers hit the bid very easily. This follows the pattern of behavior of sellers in previous price breaks, the odds and probabilities favor more downside here.

While the exact pattern the stock may follow is a guess, we can discern from the chart where support lies, at the recent breakout level, around the 130 price zone. This was a place buyers were aggressive. This would be about 15% lower than the close last Friday, and would be an area of interest IF price stops its decline.

Bottom line, follow the patterns of charts to key in on areas of interest, as these patterns are indicative of human behavior, fear and greed.

Read more here:
Human Behavior Creates Predictable Chart Patterns - Investing.com

The case of the wandering stars – Republican & Herald

Article Tools

Last month in Starwatch, I told you about the zodiac band that runs through the night sky. Because the Earth and the planets all orbit the sun in nearly the same plane, all of our fellow planets are located within it.

Back in the day, folks didnt know about any of this and saw the planets as wandering stars. In fact, they really didnt know what stars were, period. Most cultures saw them as being of a divine or godly nature. They saw patterns or pictures in the stars we call constellations, and observed them majestically slide from east to west night after night. Their predictable seasonal cycles through hundreds of years acted as clocks and calendars that helped them plan their lives. They were, and still are, infallibly reliable!

But then, as now, there were five stars that were mavericks or wild cards. Without a lot of rhyme or reason, they showed up every night in slightly different positions among the fixed stars. They would also switch directions and get brighter and fainter. Some of them even sported variations in color. They would also disappear from the skies for weeks at a time. Many cultures, including First Nation and Native Americans, saw them as greater gods and their motions and behaviors were signs of pleasure or displeasure with the mere mortals on the ground. Human behavior was controlled by these wandering stars! Drastic actions, including sacrifice took place, even human sacrifice in some cases!

Ancient Greeks referred to these independently minded wandering stars as asteres planets which is where we get the term planets. The Greeks, as well as the neighboring Romans, didnt see these planets as gods themselves, but named them after major gods in their mythology out of respect for their deity. It never hurt to kiss up! The Roman names of the planets have carried on to our present day.

The planet Mercury is named after the messenger of the gods because of its speed among the stars, just as the god Mercury was considered the first speedy delivery service. It only takes Mercury 88 days to circle the sun, flying along at more than 100,000 mph! Earth plows along at just 67,000 mph.

Venus is named after the Roman goddess of beauty and love because of its great brilliance in the sky. Little did they know what a hellhole it is. Because of a thick poisonous atmosphere complete with acid rain, the runaway greenhouse leaves the surface temperature hot enough to melt lead! Its not only not a beautiful place, its extremely hostile!

Mars is named after the Roman god of war because of its reddish tint. War meant bloodshed. Mars travels from its closest point to Earth to its farthest point from Earth in a two-year cycle. When Mars is far away its more of a pale gold in color, and when its closest to the Earth it turns bright red, symbolizing blood. Whenever Mars was bright red in the sky it was considered a warning sign of war and death. Mars was feared!

Because the planet Jupiter was so bright and stayed in one place among the stars for a lot longer than Venus, it was named in honor of the king of the Roman gods. They were right in naming Jupiter after their head god Jupiter, because its by far the largest planet in the solar system at 88,000 miles in diameter. The Romans didnt know that at the time, of course.

The planet Saturn was named after the Roman god of agriculture for reasons that arent all that clear. However, Saturn was also considered the goddess of time because it takes so long for Saturn to make a complete circuit among the stars. Saturn takes more than 29 years to make that journey, the longest of all the planets.

(Lynch, an amateur astronomer and professional broadcast meteorologist, can be reached at mikewlynch@comcast.net)

See the original post here:
The case of the wandering stars - Republican & Herald